The Joint Corp. (JYNT)
NASDAQ (CM) NASDAQ (CM) Primary 
Levi & Korsinsky Reminds Joint Stock Company Kaspi.kz Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of February 18, 2025 - KSPI
NEW YORK, NY / ACCESSWIRE / January 6, 2025 / If you suffered a loss on your Joint Stock Company Kaspi.kz (NASDAQ:KSPI) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: Click Here or contact Joseph E. Levi, Esq.
Joint Stock Company Kaspi.kz Securities Fraud Class Action Lawsuit Pending: Contact Levi & Korsinsky Before February 18, 2025 to Discuss Your Rights - KSPI
NEW YORK, NY / ACCESSWIRE / January 6, 2025 / If you suffered a loss on your Joint Stock Company Kaspi.kz (NASDAQ:KSPI) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: Click Here or contact Joseph E. Levi, Esq.
Joint Stock Company Kaspi.kz Securities Fraud Class Action Lawsuit Pending: Contact Levi & Korsinsky Before February 18, 2025 to Discuss Your Rights - KSPI
NEW YORK, NY / ACCESSWIRE / January 6, 2025 / If you suffered a loss on your Joint Stock Company Kaspi.kz (NASDAQ:KSPI) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: Click Here or contact Joseph E. Levi, Esq.
Singapore-Based CytoMed Therapeutics Stock Dips After SunAct Joins Clinical Trial As Joint Sponsor
On Monday, CytoMed Therapeutics GDTC stock is down 6.35% at $3.23 at last check Monday.
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Joint Stock Company Kaspi.kz - KSPI
NEW YORK, NY / ACCESSWIRE / January 6, 2025 / Pomerantz LLP is investigating claims on behalf of investors of Joint Stock Company Kaspi.kz ("Kaspi.kz" or the "Company") (NASDAQ:KSPI). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext.
Joint Stock Company Kaspi.kz Class Action: Levi & Korsinsky Reminds Joint Stock Company Kaspi.kz Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of February 18, 2025 - KSPI
NEW YORK, NY / ACCESSWIRE / January 6, 2025 / If you suffered a loss on your Joint Stock Company Kaspi.kz (NASDAQ:KSPI) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: Click Here or contact Joseph E. Levi, Esq.
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Joint Stock Company Kaspi.kz - KSPI
NEW YORK, NY / ACCESSWIRE / January 5, 2025 / Pomerantz LLP is investigating claims on behalf of investors of Joint Stock Company Kaspi.kz ("Kaspi.kz" or the "Company") (NASDAQ:KSPI). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext.
Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of February 18, 2025 in Joint Stock Company Kaspi.kz Lawsuit - KSPI
NEW YORK, NY / ACCESSWIRE / January 5, 2025 / If you suffered a loss on your Joint Stock Company Kaspi.kz (NASDAQ:KSPI) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: Click Here or contact Joseph E. Levi, Esq.
Levi & Korsinsky Notifies Joint Stock Company Kaspi.kz Investors of a Class Action Lawsuit and Upcoming Deadline - KSPI
NEW YORK, NY / ACCESSWIRE / January 3, 2025 / If you suffered a loss on your Joint Stock Company Kaspi.kz (NASDAQ:KSPI) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: Click Here or contact Joseph E. Levi, Esq.
ROSEN, A TRUSTED AND LONGSTANDING FIRM, Encourages Joint Stock Company Kaspi.kz Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm - KSPI
NEW YORK CITY, NY / ACCESSWIRE / January 3, 2025 / WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Joint Stock Company Kaspi.kz (NASDAQ:KSPI) between January 19, 2024 and September 19, 2024, both dates inclusive (the "Class Period"), of the important February 18, 2025 lead plaintiff deadline in the securities class action first filed by the Firm. SO WHAT: If you purchased Kaspi.kz securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.
Joint Stock Company Kaspi.kz Class Action: Levi & Korsinsky Reminds Joint Stock Company Kaspi.kz Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of February 18, 2025 - KSPI
NEW YORK, NY / ACCESSWIRE / January 3, 2025 / If you suffered a loss on your Joint Stock Company Kaspi.kz (NASDAQ:KSPI) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: Click Here or contact Joseph E. Levi, Esq.
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Joint Stock Company Kaspi.kz - KSPI
NEW YORK CITY, NY / ACCESSWIRE / January 3, 2025 / Pomerantz LLP is investigating claims on behalf of investors of Joint Stock Company Kaspi.kz ("Kaspi.kz" or the "Company") (NASDAQ:KSPI). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext.
